Abstract:The convenient and precise fabrication of drug-hydrogel formulations with satisfactory degradability and a well-controlled drug release profile are crucial factors for injectable hydrogel formulations in clinical applications. Here a new injectable thermosensitive hydrogel formed from poly(ε-caprolactone) (PCL)-poly(ethylene glycol)-poly(ε-caprolactone) amphiphilicco-polymers with 1,4,8-trioxa[4.6]spiro-9-undecanone (TOSUO) moieties incorporated in the poly(ε-caprolactone) (PCL)block (PECT) was constructed to provide a route to tailor the degradation and drug release behavior. The effect of hydrophilic cyclic ether moieties on the degradation of and drug release by PECT hydrogels were evaluated in vitro and in vivo. The results indicated that a freeze-dried powder of paclitaxel-loaded PECT nanoparticles rapidly dissolved in water at ambient temperature with slightly shaking and formed a stable injectable in situ drug-hydrogel formulation at body temperature, which is convenient for clinical operations because it avoids the need for pre-quenching or long-term incubation. The paclitaxel distribution was also more quantitative and homogeneous on entrapping paclitaxel in PECT nanoparticles. Further, the small number of pendant cyclic ether groups in PCL could decrease the cystallinity and hydrophobicity and, as a result, the in vitro and in vivo retention time of PECT hydrogels and the release of entrapped paclitaxel could be tuned from a few weeks to months by varying the amount of PTOSUO in the hydrophobic block. Significantly, paclitaxel-loaded PECT nanoparticles and free paclitaxel could be simultaneously released during the in vitro paclitaxel release from PECT hydrogels. A histopathological evaluation indicated that in vivo injected PECT hydrogels produced only a modest inflammatory response. Thus pendant cyclic ether modification of PCL could be an effective way to achieve the desired degradation and drug release profiles of amphiphilicco-polymer thermosensitive hydrogels and PECT hydrogels may be suitable for local drug delivery.

CELLULOSE-GRAFT-POLY(L-LACTIDE) AS A DEGRADABLE DRUG-DELIVERY SYSTEM: SYNTHESIS, DEGRADATION AND DRUG RELEASE

The synthesis of biodegradable graft copolymer cellulose-graft-poly(L-lactide) and the study of its controlled drug release.

Adjustable Degradation and Drug Release of a Thermosensitive Hydrogel Based on a Pendant Cyclic Ether Modified Poly(ε-Caprolactone) and Poly(ethylene Glycol)co-Polymer

Modulating Drug Release from Short Poly(ethylene Glycol) Block Initiated Poly(L-lactide) Di-block Copolymers

Chitosan-poly(ε-caprolactone)-poly(ethylene glycol) graft copolymers: synthesis, self-assembly, and drug release behavior.

Nanofiber Prepared by Intermittent Electrospun as Controlled Drug Delivery

Preparation and properties of a biodegradable polymer as a novel drug delivery system

SYNTHESIS AND CHARACTERIZATION OF CELLULOSE-GRAFT-POLY (L-LACTIDE) VIA RING-OPENING POLYMERIZATION

Synthesis and Drug Controlled Release of Block Copolymers of Poly(l‐lactide) with Poly(d, L‐lactide) and Related Monomers

Erosion Induced Controllable Release of Gliclazide Encapsulated Inside Degradable Polymeric Particles

Development of A New Poly(Ethylene Glycol)-Graft-Poly(D,L-Lactic Acid) As Potential Drug Carriers

Controllable Biodegradation and Drug Release Behavior of Chitosan-Graft-poly(d, L-lactic Acid) Synthesized by an Efficient Method

Poly(vinylcaprolactam)-Based Biodegradable Multiresponsive Microgels for Drug Delivery

Cellulose nanocrystals/polyethylene glycol as bifunctional reinforcing/compatibilizing agents in poly(lactic acid) nanofibers for controlling long-term in vitro drug release

Effect of Degradable Polymer Swelling Property on Release Performance of Controlled Drug Delivery System

Synthesis and degradation of a new poly (ethylene glycol)-graft-poly(D,L-lactic acid)

Formation and Degradation of Poly(d,l-Lactide) Nanoparticles and Their Potential Application As Controllable Releasing Devices.

Synthesis Of Degradable Poly(Polyamidoamine-Methacrylamide-G-Anhydride) Photocrosslinked Gels And Their Controlled Drug Release Behavior

Characteristics of Biodegradable Implantable Drug Delivery System with Micro-Porous Structure

Characterizing the drug release from the hydrogel drug delivery system incorporated with biodegradable microspheres

In Vitro Degradation and Controlled Release Behavior of D,L-PLGA50 and PCL-b-D,L-PLGA50 Copolymer Microspheres.